ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time
ProPhase Labs (NASDAQ: PRPH) announced a conference call scheduled for March 31, 2021, at 4:30 p.m. ET, to discuss its fourth quarter and full year results for 2020. The call will be hosted by CEO Ted Karkus, followed by a Q&A session. Investors can access the call via a toll-free number or an international dial-in number. The company provides testing for COVID-19 and related respiratory pathogens through its subsidiary, ProPhase Diagnostics. A replay of the call will be available until April 14, 2021.
- ProPhase Diagnostics offers quick COVID-19 testing results in under 24 hours.
- The company is actively pursuing strategic investments and acquisitions.
- None.
GARDEN CITY, NY, March 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2020. A press release detailing these results will be issued prior to the call.
ProPhase Labs CEO and Chairman of the Board of Directors Ted Karkus will host the conference call, followed by a question and answer period.
To access the call, please use the following information:
| Date: | Wednesday, March 31, 2021 | |
| Time: | 4:30 p.m. Eastern time, 1:30 p.m. Pacific time | |
| Toll-free dial-in number: | 1-877-407-0784 | |
| International dial-in number: | 1-201-689-8560 | |
| Conference ID: | 13717366 |
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact MZ Group at 1-949-491-8235.
The conference call will be broadcast live and available for replay at http://public.viavid.com/index.php?id=143875 and via the investor relations section of the Company's website at www.ProPhaseLabs.com.
A replay of the conference call will be available after 7:30 p.m. Eastern time through April 14, 2021.
| Toll-free replay number: | 1-844-512-2921 | |
| International replay number: | 1-412-317-6671 | |
| Replay ID: | 13717366 |
About ProPhase Labs
ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company. The Company’s laboratory testing subsidiary, ProPhase Diagnostics, offers SARS-CoV-2 (COVID-19) and COVID-19 viral mutation PCR tests through both saliva and nasal swab methods at its CLIA certified laboratories. Critical to Covid testing, results are typically provided in under 24 hours. ProPhase Diagnostics also provides Respiratory Pathogen Panel (RPP) Molecular tests including Influenza A and B and others. ProPhase Labs researches, develops, manufactures, distributes, markets and sells OTC consumer healthcare products and dietary supplements, including dietary supplements under the TK Supplements® brand. The Company actively pursues strategic investments and acquisition opportunities for other companies, technologies and products. For more information, visit www.ProPhaseLabs.com.
Investor Contact
Chris Tyson
Managing Director
MZ Group - MZ North America
949-491-8235
PRPH@mzgroup.us
www.mzgroup.us
FAQ
What are the details of the ProPhase Labs conference call?
How can I access the ProPhase Labs conference call?
What will be discussed in the ProPhase Labs conference call?
Is there a replay available for the ProPhase Labs conference call?
